|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.41 USD | +0.20% |
|
-0.27% | +37.35% |
| Apr. 03 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
| Mar. 08 | XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
XOMA Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 4.76 million compared to USD 6.03 million a year ago. Net loss was USD 40.83 million compared to USD 17.1 million a year ago.
Basic loss per share from continuing operations was USD 4.04 compared to USD 1.98 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +37.35% | 296M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
XOMA CORPORATION 
